Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

[Nutrition and gastronomy in the community of Cantabria].

Castañar García Gómez MDM, Montalbán C, Cruz Tamayo F.

Nutr Hosp. 2019 Jul 2;36(Spec No1):21-28. doi: 10.20960/nh.02688. Spanish.

2.

Cortisol and adrenal androgens as independent predictors of mortality in septic patients.

De Castro R, Ruiz D, Lavín BA, Lamsfus JÁ, Vázquez L, Montalban C, Marcano G, Sarabia R, Paz-Zulueta M, Blanco C, Santibáñez M.

PLoS One. 2019 Apr 4;14(4):e0214312. doi: 10.1371/journal.pone.0214312. eCollection 2019.

3.

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.

Barranco GI, Fernández S, Oña R, González-Rincón J, Martínez-Ramírez A, Teijo A, Camacho FI, Pinedo FJ, Sánchez-Beato M, Pedrosa L, de la Fuente A, Estévez M, Iglesias R, Montalbán C, García JF.

Haematologica. 2019 Jul;104(7):e326-e329. doi: 10.3324/haematol.2018.214981. Epub 2019 Mar 19. No abstract available.

4.

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma.

Mata E, Fernández S, Astudillo A, Fernández R, García-Cosío M, Sánchez-Beato M, Provencio M, Estévez M, Montalbán C, Piris MA, García JF.

Blood Cancer J. 2019 Mar 11;9(3):34. doi: 10.1038/s41408-019-0195-7. No abstract available.

5.

Bone mineral density evolution and incidence of fractures in a cohort of patients with primary hyperparathyroidism treated with parathyroid surgery vs active surveillance during 6 years of follow-up.

Ramos L, Piedra M, Muñoz P, Vázquez LA, García-Unzueta MT, Montalbán C, Amado JA.

Endocrinol Diabetes Nutr. 2019 Jan;66(1):41-48. doi: 10.1016/j.endinu.2018.05.010. Epub 2018 Jul 6. English, Spanish.

PMID:
30616776
6.

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma.

González-Barca E, Coronado M, Martín A, Montalbán C, Montes-Moreno S, Panizo C, Rodríguez G, Sancho JM, López-Hernández A; Spanish Lymphoma Group (GELTAMO).

Oncotarget. 2018 Aug 17;9(64):32383-32399. doi: 10.18632/oncotarget.25892. eCollection 2018 Aug 17. Review.

7.

Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.

Montalbán C, Díaz-López A, Martín A, Baile M, Sanchez JM, Sancho JM, García O, Novelli S, Monter-Rovira A, Salar A, Bastos M, Gutiérrez A, Bento L, Córdoba R, Arquero T, González de Villambrosia S, Barranco G, De Oña R, López Guillermo A, Rodriguez Salazar MJ, Domínguez JF, Fernández R, Queizan JA, Rodríguez J, Abraira V, García JF; GELTAMO-IPI Project Investigators.

Br J Haematol. 2018 Aug;182(4):534-541. doi: 10.1111/bjh.15446. Epub 2018 Jul 5.

PMID:
29978453
8.

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.

Mata E, Díaz-López A, Martín-Moreno AM, Sánchez-Beato M, Varela I, Mestre MJ, Santonja C, Burgos F, Menárguez J, Estévez M, Provencio M, Sánchez-Espiridión B, Díaz E, Montalbán C, Piris MA, García JF.

Oncotarget. 2017 Nov 30;8(67):111386-111395. doi: 10.18632/oncotarget.22799. eCollection 2017 Dec 19.

9.

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine.

Montalban C, Montellano MB, Santos J, Lavis N.

Hum Vaccin Immunother. 2018 Mar 4;14(3):593-595. doi: 10.1080/21645515.2017.1377378. Epub 2017 Oct 30.

10.

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.

Salar A, Domingo-Domenech E, Panizo C, Nicolás C, Bargay J, Muntañola A, Canales M, Bello JL, Sancho JM, Tomás JF, Rodríguez MJ, Peñalver J, Grande C, Sánchez-Blanco JJ, Palomera L, Arranz R, Conde E, García M, García JF, Caballero D, Montalbán C.

Blood. 2017 Oct 12;130(15):1772-1774. doi: 10.1182/blood-2017-07-795302. Epub 2017 Aug 11. No abstract available.

11.

Clinical features and management of non-gastrointestinal non-ocular extranodal mucosa associated lymphoid tissue (ENMALT) marginal zone lymphomas.

Matutes E, Montalban C.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):99-108. doi: 10.1016/j.beha.2016.07.005. Epub 2016 Nov 5. Review.

PMID:
28288723
12.

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.

Montalbán C, Díaz-López A, Dlouhy I, Rovira J, Lopez-Guillermo A, Alonso S, Martín A, Sancho JM, García O, Sánchez JM, Rodríguez M, Novelli S, Salar A, Gutiérrez A, Rodríguez-Salazar MJ, Bastos M, Domínguez JF, Fernández R, Gonzalez de Villambrosia S, Queizan JA, Córdoba R, de Oña R, López-Hernandez A, Freue JM, Garrote H, López L, Martin-Moreno AM, Rodriguez J, Abraira V, García JF; GELTAMO-IPI Project Investigators.

Br J Haematol. 2017 Mar;176(6):918-928. doi: 10.1111/bjh.14489. Epub 2017 Jan 20.

PMID:
28106247
13.

Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group.

Guisado-Vasco P, Montalban C, García JF; Spanish Hodgkin Lymphoma Study Group.

Br J Haematol. 2017 Jul;178(2):336-338. doi: 10.1111/bjh.14127. Epub 2016 May 2. No abstract available.

PMID:
27135208
14.

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.

Batlle-López A, González de Villambrosía S, Francisco M, Malatxeberria S, Sáez A, Montalban C, Sánchez L, Garcia J, González-Barca E, López-Hernández A, Ruiz-Marcellan MC, Mollejo M, Grande C, Richards KL, Hsi ED, Tzankov A, Visco C, Xu-Monette ZY, Cao X, Young KH, Piris MÁ, Conde E, Montes-Moreno S.

Oncotarget. 2016 Apr 5;7(14):18036-49. doi: 10.18632/oncotarget.7495.

15.

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.

Borja-Tabora CF, Montalban C, Memish ZA, Boutriau D, Kolhe D, Miller JM, Van der Wielen M.

BMC Infect Dis. 2015 Oct 6;15:409. doi: 10.1186/s12879-015-1138-y.

16.

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.

Salar A, Domingo-Domenech E, Panizo C, Nicolás C, Bargay J, Muntañola A, Canales M, Bello JL, Sancho JM, Tomás JF, Rodríguez MJ, Peñalver FJ, Grande C, Sánchez-Blanco JJ, Palomera L, Arranz R, Conde E, García M, García JF, Caballero D, Montalbán C; Grupo Español de Linfomas/Trasplante de Médula Ósea (GELTAMO).

Lancet Haematol. 2014 Dec;1(3):e104-11. doi: 10.1016/S2352-3026(14)00021-0. Epub 2014 Nov 19.

PMID:
27029228
17.

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Mollejo M, Menárguez J, Guisado-Vasco P, Bento L, Algara P, Montes-Moreno S, Rodriguez-Pinilla MS, Cruz MA, Casado F, Montalbán C, Piris MA.

Mod Pathol. 2014 Feb;27(2):281-93. doi: 10.1038/modpathol.2013.120. Epub 2013 Aug 9.

18.

Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.

Montalban C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E, Mollejo M, Matutes E, Ferreri AJ, Salar A, Rattotti S, Carpaneto A, Perez R, Bello JL, Hernandez M, Caballero D, Carbonell F, Piris MA; Splenic Marginal Zone Lymphoma Study Group (SMZLSG).

Leuk Lymphoma. 2014 Apr;55(4):929-31. doi: 10.3109/10428194.2013.818143. Epub 2013 Jul 29. No abstract available.

PMID:
23799931
19.

MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.

Sánchez-Espiridión B, Martín-Moreno AM, Montalbán C, Figueroa V, Vega F, Younes A, Medeiros LJ, Alvés FJ, Canales M, Estévez M, Menarguez J, Sabín P, Ruiz-Marcellán MC, Lopez A, Sánchez-Godoy P, Burgos F, Santonja C, López JL, Piris MA, Garcia JF.

Br J Haematol. 2013 Aug;162(3):336-47. doi: 10.1111/bjh.12390. Epub 2013 Jun 1.

20.

Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.

Fernández-Guarino M, Ortiz-Romero PL, Fernández-Misa R, Montalbán C.

Actas Dermosifiliogr. 2014 Jun;105(5):438-45. doi: 10.1016/j.ad.2012.10.021. Epub 2013 Mar 26. Review. English, Spanish.

PMID:
23540593
21.
22.

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.

Montalbán C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E, Mollejo M, Matutes E, Ferreri A, Salar A, Rattotti S, Carpaneto A, Pérez Fernández R, Bello JL, Hernández M, Caballero D, Carbonell F, Piris MA; Splenic Marginal Zone Lymphoma Study Group.

Br J Haematol. 2012 Oct;159(2):164-71. doi: 10.1111/bjh.12011. Epub 2012 Aug 24. Erratum in: Br J Haematol. 2013 Sep;162(6):864. Iannito, Emilio [corrected to Iannitto, Emilio].

PMID:
22924582
23.

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F, Montalbán C, Stelitano C, Cabrera ME, Giordano Resti A, Politi LS, Doglioni C, Cavalli F, Zucca E, Ponzoni M, Dolcetti R.

J Clin Oncol. 2012 Aug 20;30(24):2988-94. doi: 10.1200/JCO.2011.41.4466. Epub 2012 Jul 16. Erratum in: J Clin Oncol. 2012 Nov 1;30(31):3903.

PMID:
22802315
24.

Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.

Sánchez-Espiridión B, Martin-Moreno AM, Montalbán C, Medeiros LJ, Vega F, Younes A, Piris MA, Garcia JF.

Haematologica. 2012 Jul;97(7):1080-4. doi: 10.3324/haematol.2011.055459. Epub 2012 Feb 7.

25.

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.

Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group.

Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31.

PMID:
22185637
26.

Evaluation of a rapid assay for identification of Mycobacterium tuberculosis grown in solid and liquid media.

Ang CF, Cajucom MA, Kim Y, Bang H, Lee H, Cho SN, Montalban CS.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1475-7, i. doi: 10.5588/ijtld.10.0709.

PMID:
22008759
27.

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.

Montes-Moreno S, Montalbán C, Piris MA.

Leuk Lymphoma. 2012 Feb;53(2):185-94. doi: 10.3109/10428194.2011.608447. Epub 2011 Sep 19. Review.

PMID:
21812534
28.

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA.

Blood. 2011 Jul 28;118(4):1034-40. doi: 10.1182/blood-2010-11-321554. Epub 2011 Jun 1.

29.

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.

Ruskoné-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F, Montalban C, Raderer M, Savio A, Wotherspoon A; EGILS group.

Gut. 2011 Jun;60(6):747-58. doi: 10.1136/gut.2010.224949. Epub 2011 Feb 11.

PMID:
21317175
30.

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).

Tomás JF, Montalbán C, De Sevilla AF, Martínez-López J, Díaz N, Canales M, Martínez R, Sánchez-Godoy P, Caballero MD, Peñalver J, Prieto E, Salar A, Burgaleta C, Queizán JA, Bajo R, De Oña R, De La Serna J.

Leuk Lymphoma. 2011 Mar;52(3):409-16. doi: 10.3109/10428194.2010.543717. Epub 2011 Jan 28.

PMID:
21275633
31.

Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells.

Camacho FI, Bellas C, Corbacho C, Caleo A, Arranz-Sáez R, Cannata J, Menárguez J, Sánchez-Verde L, González-Camacho L, Pérez-Martín ME, Martínez-González MA, Alvaro T, Mollejo M, Ruíz-Marcellán C, Montalbán C, Piris MA.

Mod Pathol. 2011 May;24(5):698-707. doi: 10.1038/modpathol.2010.237. Epub 2011 Jan 14.

32.

Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.

Rivero A, Rapado I, Tomás JF, Montalbán C, de Oña R, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, de Sevilla AF, de la Serna J, Martínez-López J.

Leuk Res. 2011 Apr;35(4):431-7. doi: 10.1016/j.leukres.2010.09.026. Epub 2010 Oct 27.

PMID:
21030078
33.

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.

Sánchez-Espiridión B, Montalbán C, López A, Menárguez J, Sabín P, Ruiz-Marcellán C, Lopez A, Ramos R, Rodríguez J, Cánovas A, Camarero C, Canales M, Alves J, Arranz R, Acevedo A, Salar A, Serrano S, Bas A, Moraleda JM, Sánchez-Godoy P, Burgos F, Rayón C, Fresno MF, Laraña JG, García-Cosío M, Santonja C, López JL, Llanos M, Mollejo M, González-Carrero J, Marín A, Forteza J, García-Sanz R, Tomás JF, Morente MM, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group.

Blood. 2010 Aug 26;116(8):e12-7. doi: 10.1182/blood-2010-02-270009. Epub 2010 May 17.

34.

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.

Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G, Mollejo M, García JF, Menarguez J, Montalbán C, Ruiz-Marcellan MC, Conde E, Piris MA.

Haematologica. 2010 Aug;95(8):1342-9. doi: 10.3324/haematol.2009.016113. Epub 2010 Apr 23.

35.

Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.

Kanellis G, Mollejo M, Montes-Moreno S, Rodriguez-Pinilla SM, Cigudosa JC, Algara P, Montalban C, Matutes E, Wotherspoon A, Piris MA.

Haematologica. 2010 Jul;95(7):1122-9. doi: 10.3324/haematol.2009.013714. Epub 2010 Mar 10.

36.

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.

Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, Fraile G, Montalbán C.

Cancer. 2009 Nov 15;115(22):5210-7. doi: 10.1002/cncr.24605.

37.

Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.

Martínez-López J, Rivero A, Rapado I, Montalbán C, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, Fernández de Sevilla A, Peñalver FJ, Gonzalez M, Prieto E, Salar A, Burgaleta C, Queizán JA, Peñarrubia MJ, Monteagudo MD, Cabrera C, De la Serna J, Tomás JF.

Leuk Lymphoma. 2009 Aug;50(8):1283-9. doi: 10.1080/10428190903040006.

PMID:
19557622
38.

A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.

Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, Poderos C, Bellas C, Fresno MF, Morante C, Mestre MJ, Mendez M, Mazorra F, Conde E, Castaño A, Sánchez-Godoy P, Tomas JF, Morente MM, Piris MA, García JF; Spanish Hodgkin's Lymphoma Study Group.

Clin Cancer Res. 2009 Feb 15;15(4):1367-75. doi: 10.1158/1078-0432.CCR-08-1119.

39.

Rabies awareness in eight Asian countries.

Dodet B, Goswami A, Gunasekera A, de Guzman F, Jamali S, Montalban C, Purba W, Quiambao B, Salahuddin N, Sampath G, Tang Q, Tantawichien T, Wimalaratne O, Ziauddin A.

Vaccine. 2008 Nov 25;26(50):6344-8. doi: 10.1016/j.vaccine.2008.09.003. Epub 2008 Sep 18.

PMID:
18804507
40.

Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21).

Santón A, García-Cosio M, Bellosillo B, Rodríguez P, Cristóbal E, Serrano S, Besses C, Abraira V, Salar A, Montalbán C.

Leuk Lymphoma. 2008 Aug;49(8):1516-22. doi: 10.1080/10428190802210692.

PMID:
18766964
41.

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.

Ferreri AJ, Dognini GP, Bairey O, Szomor A, Montalbán C, Horvath B, Demeter J, Uziel L, Soffietti R, Seymour JF, Ambrosetti A, Willemze R, Martelli M, Rossi G, Candoni A, De Renzo A, Doglioni C, Zucca E, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group.

Br J Haematol. 2008 Oct;143(2):253-7. doi: 10.1111/j.1365-2141.2008.07338.x. Epub 2008 Aug 10.

PMID:
18699850
42.

[Importance of artificial nutrition in the resolution and etiologic diagnosis of severe chronic diarrhea: a propos of a case].

Arrieta FJ, Gómez FJ, Aragón C, Rueda A, Balsa JA, Zamarrón I, Carrero C, Botella Carretero JI, Montalbán C, Vázquez C.

Nutr Hosp. 2008 Jul-Aug;23(4):408-10. Spanish.

PMID:
18604328
43.

Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features.

Díaz-Alderete A, Doval A, Camacho F, Verde L, Sabin P, Arranz-Sáez R, Bellas C, Corbacho C, Gil J, Perez-Martín M, Ruiz-Marcellán M, Gonzalez L, Montalbán C, Piris M, Menarguez J.

Leuk Lymphoma. 2008 Jan;49(1):95-101. doi: 10.1080/10428190701742472. Erratum in: Leuk Lymphoma. 2008 Mar;49(3):598.

PMID:
18203018
44.

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Solé F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA.

Leukemia. 2008 Mar;22(3):487-95. Epub 2007 Dec 20. Review.

PMID:
18094718
45.

Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.

Domingo-Domènech E, Benavente Y, González-Barca E, Montalban C, Gumà J, Bosch R, Wang SS, Lan Q, Whitby D, Fernández de Sevilla A, Rothman N, de Sanjosé S.

Haematologica. 2007 Nov;92(11):1475-81.

46.

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renz AO, Doglioni C, Montalbán C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Dalla Libera A, Pertoldi B, Horváth B, Szomor A, Zucca E, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group (IELSG).

Haematologica. 2007 Apr;92(4):486-92.

47.

Primary diffuse large B-cell lymphoma of the stomach.

Ferreri AJ, Montalbán C.

Crit Rev Oncol Hematol. 2007 Jul;63(1):65-71. Epub 2007 Mar 6. Review.

PMID:
17339119
48.

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.

Sánchez-Aguilera A, Montalbán C, de la Cueva P, Sánchez-Verde L, Morente MM, García-Cosío M, García-Laraña J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menárguez J, Sabín P, Mestre MJ, Méndez M, Fresno MF, Nicolás C, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group.

Blood. 2006 Jul 15;108(2):662-8. Epub 2006 Mar 21.

49.

Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.

Montalban C, Norman F.

Expert Rev Anticancer Ther. 2006 Mar;6(3):361-71. Review.

PMID:
16503853
50.

Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.

Montalban C, Santón A, Redondo C, García-Cosio M, Boixeda D, Vazquez-Sequeiros E, Norman F, de Argila CM, Alvarez I, Abraira V, Bellas C.

Ann Oncol. 2005 Sep;16(9):1539-44. Epub 2005 Jun 9.

PMID:
15946976

Supplemental Content

Loading ...
Support Center